Clinical Trials

Cancer

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 10 of 145 Clinical Trials Related to Cancer

Clinical Research Trial

URCC-21038 Observational

A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 Immunotherapy in a Community Oncology Setting

Doctor(s) Running This Study
Clinical Research Trial

MSK 23-098

MSK 23-098 A Phase II study of IO102/IO103 and nivolumab-relatlimab fixed dose combination in untreated, unresectable Stage III/IV melanoma

Doctor(s) Running This Study
Clinical Research Trial

A012103 Breast Cancer

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Doctor(s) Running This Study
Clinical Research Trial

Alliance A032101

A032101 Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)

Doctor(s) Running This Study
Clinical Research Trial

SWOG S1914 Lung Cancer

A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT versus SBRT Alone in High Risk, Early Stage NSCLC

Doctor(s) Running This Study
Clinical Research Trial

EA9181

EA9181 A Phase III Randomized Trial of Steroids + Tyrosine Kinase Inhibitor (TKI) Induction with Chemotherapy or Blinatumomab for Newly Diagnosed BCR-ABL-positive Acute Lymphoblastic Leukemia (ALL) in Adults

Doctor(s) Running This Study
Clinical Research Trial

A022004

Randomized Trial of Consolidation Targeted Adjuvant Therapy with Encorafenib and Cetuximab Versus Usual Care for Patients with State II/III BRAF V600E Colon Cancer

Doctor(s) Running This Study
Clinical Research Trial

EAY191-N2 Breast Cancer

PHASE 2 TRIAL OF FULVESTRANT AND BINIMETINIB IN PATIENTS WITH HORMONE RECEPTOR-POSITIVE METASTATIC BREAST CANCER WITH A FRAMESHIFT OR NONSENSE MUTATION OR GENOMIC DELETION IN NF1

Doctor(s) Running This Study